SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-23-009630
Filing Date
2023-03-29
Accepted
2023-03-29 07:34:45
Documents
85
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K avtx-20221231.htm   iXBRL 10-K 2204944
2 EX-23.1 ex-2312022.htm EX-23.1 15233
3 EX-31.1 ex-3112022.htm EX-31.1 10634
4 EX-31.2 ex-3122022.htm EX-31.2 10420
5 EX-32.1 ex-3212022.htm EX-32.1 11185
11 GRAPHIC avtx-20221231_g1.jpg GRAPHIC 520109
  Complete submission text file 0001628280-23-009630.txt   10616600

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avtx-20221231.xsd EX-101.SCH 67726
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avtx-20221231_cal.xml EX-101.CAL 90849
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avtx-20221231_def.xml EX-101.DEF 397713
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avtx-20221231_lab.xml EX-101.LAB 870734
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avtx-20221231_pre.xml EX-101.PRE 579756
79 EXTRACTED XBRL INSTANCE DOCUMENT avtx-20221231_htm.xml XML 1100798
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37590 | Film No.: 23771777
SIC: 2834 Pharmaceutical Preparations